Peri-Myocarditis as a Dire Consequence of Coronavirus Disease: A Clinical Challenge

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 4; p. e58739
• Main Authors: Pakala, Ramya, Grewal, Niyati, Yi, Jin, Urooj, Fatima
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 22.04.2024; Cureus
• Subjects: Acute coronary syndromes; Cardiac arrest; Cardiac arrhythmia; Cardiac catheterization; Cardiology; Case reports; Coronaviruses; COVID-19 vaccines; Cytokine storm; Electrocardiography; Heart failure; Hemodynamics; Hypotension; Infections; Infectious Disease; Internal Medicine; Intubation; Ischemia; Literature reviews; Myocarditis; Peptides; Pericarditis; Pericardium; Pulmonary arteries; Tomography; Ultrasonic imaging; Viral infections; cardiovascular disease; coronavirus; ventricular dysfunction; cardiomyopathy; myocarditis
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.58739

Myocarditis is an inflammation of the heart muscle, most commonly caused by viral infections, with other contributing factors including medications or systemic inflammatory conditions. Coronavirus disease 2019 (COVID-19) is a disease caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2 virus). In this report, we present a case of fulminant myocarditis in a patient with COVID-19 infection. Fulminant myocarditis is an aggressively progressive and severe variant that can result in substantial cardiac impairment. We present a case of fulminant myocarditis with a unique time course, progression, and potential challenges faced in diagnosis and management. Healthcare providers need to remain vigilant and anticipate the potential rapid progression of this disease.